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1. Introduction  
The pulmonary-renal syndrome involves the combination of diffuse alveolar hemorrhage 
and a rapid progressive glomerulonephritis (RPGN). It is usually a systemic vasculitis that 
can led through a vast vasculitic process to life-threatening injury to the involved organs 
lung and kidney [Niles 1996, Salant 1987, Boyce 1986, Gallagher 2002 & De Groot 2005].  
In the differential diagnosis other diseases of acute renal and lung injury with alveolar 
hemorrhage without RPGN have to be discussed.  
2. Pulmonary-renal syndrome  
The diffuse alveolar hemorrhage is defined by the triad of hemoptysis, diffuse alveolar infiltrates 
and low hematocrit. However, the clinical presentation is variable (slight cough, progressive 
dyspnea, manifest hemoptysis) and these symptoms don`t have to occur simultaneously 
[Hauber 2007]. Slowly protracted courses through to fulminant organ failure are described.  
A rapid-progressive glomerulonephritis (RPGN) is manifested by a rapidly progressive renal 
function loss (a few days to few weeks) and the presence of a nephritic sediment with 
deformed erythrocytes of a glomerular origin and possibly red cell casts.  
2.1 Pathophysiology  
The underlying cause of a pulmonary-renal syndrome is usually a systemic vasculitis of the 
small pulmonary and renal vessels. These vasculitides have a heterogeneous pathogenesis - 
there are three different pathophysiological mechanisms of injury [Niles 1996, Salant 1987 & 
De Groot 2005]:  
1. mediated by anti-neutrophil-cytoplasmic antibodies (ANCA),  
2. immune-complex mediated vasculitis of small vessels or 
3. by antibodies against the glomerular basement membrane (Goodpasture  Syndrome).  
In the kidney a RPGN is caused by damage of the capillaries and basal membranes with 
leakage of erythrocytes, followed by an influx of macrophages, fibrinogen and the formation 
of extracapillary cell proliferation (so called crescents) [Salant 1987].  
In the lungs, a diffuse alveolar hemorrhage is caused by a pulmonary capillaritis [Hauber 2007]. 
In the case of ANCA-associated systemic vasculitis the detection of ANCA is possible in ~ 
80% of patients. Besides the correlation of ANCA titers with disease activity, there is 
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evidence of a pathogenetic role of ANCA. Myeloperoxidase (MPO) and proteinase 3 (Pr3) 
are detected in the cytoplasm of non-stimulated neutrophils. It is assumed that cytokines 
(e.g. TNF, interleukins) raise the expression of Pr3 and MPO on the cell surface of 
granulocytes and thus a reaction of these antigens with ANCA is possible. This process 
leads to activation of granulocytes and release of adhesion molecules to the interaction of 
leukocytes with vascular endothelial cells. Finally cell necrosis and apoptosis contribute to 
vascular inflammation process [Bosch 2006].  
2.2 Diagnosis  
2.2.1 Basic steps  
As with any systemic vasculitis the diagnosis of pulmonary-renal syndrome is made in three 
steps:  
1. Adequate evaluation and networking of existing and past patient's symptoms.  
2. Establishing the diagnosis by laboratory, technical and biopsy examinations.  
3. Differential diagnosis of vasculitis.  
2.2.2 Imaging  
The value of imaging refers to the extent of pulmonary capillaritis resulting in diffuse alveolar 
hemorrhage: in a conventional X-ray or in a computer tomography of the chest confluent or 
mixed interstitial-alveolar infiltrates are found (Fig. 1).  
 
 
Fig. 1. Diffuse alveolar hemorrhage in chest x-ray in Wegener's granulomatosis. 
In a RPGN sonographically enlarged kidneys presents with a wide  parenchym area. 
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2.2.3 Serology  
Antibodies against the glomerular basement membrane (GBM) can be found typically in the 
rare Goodpasture's syndrome (Tab. 1).  
The above briefly described heterogeneous pathogenesis of small vessels vasculitis results in 
the immunological classification considering serological / immunological parameters such 
as anti-neutrophil-cytoplasmic antibodies (ANCA) by immunfluorescence-optical findings 
(perinuclear or cytoplasmtic fluorescence) or ELISA against the target antigen proteinase 3 
or myeloperoxidase (Tab. 1) [Bosch 2006]. In addition, the eosinophils, IgE and the extended 
autoimmunserology: anti-nuclear factor (ANA), anti-ds-DNA, C3, C4 and cryoglobulins can 
be determined.  
 
Disease 
Proteinase-3-
Antibody 
Myeloperoxidase     
(MPO-)-Antibody 
ANCA  
negative 
Anti-GBM-
Ab 
Wegener`s 
Granulomatosis 
70 % 20 % 10 % <10% 
Microscopic 
Polyangiitis 
30 % 60 % 10 % <10% 
Churg-Strauss-
Syndrome 
10 % 60 % 30 % <10% 
Goodpasture 
Syndrome 
<10% <30% 70% 95% 
Table 1. ANCA-Sensitivity.  
The rapid availability of these antibodies has improved the time to establish an early 
diagnosis, which is prognostically relevant [Saxena 1995].  
2.2.4 Renal biopsy  
The diagnosis of RPGN is done by renal biopsy: in light microscopy there is a 
glomerulonephritis with crescent formation in the Bowman's capsule compartment 
(extracapillary proliferation) in more than 50% of the glomeruli. The further work is carried 
out by immunohistochemistry and electron microscopy.  
In immunohistology, the type of immunoglobulins and the deposition pattern (capillary, 
mesangial, granular, linear along the glomerular basement membrane) differ. Only in 
Goodpasture syndrome, linear deposits are found along the glomerular basement 
membrane. In case of an ANCA triggered form immune deposits are missing (pauci-
immune RPGN). In contrast, in immune-complex vaculitis there can be found a different 
picture, usually with granular deposition of IgG, IgM, IgA or complement.  
2.2.5 Bronchoscopy 
The diagnosis of diffuse alveolar hemorrhage includes the clinical picture and a brochoscopy 
with a bronchoalveolar lavage and the microscopic detection of siderophages. Especially in 
the case of diffuse infiltrates in imaging without hemopytsis a bronchoscopy can be helpful 
and a definite diagnosis can be established [Hauber 2007].  
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3. Differential diagnosis of the pulmonary-renal syndrome  
As already stated the pulmonary-renal syndrome is usally caused by a systemic small 
vessels vasculitis (Tab. 2), these can be categorized [Niles 1996, Salant 1987, De Groot 2005, 
Jennette 1994 & Falk 1997]:  
- morphological criteria (size of the infesting vessels, presence or absence of granulomas),  
- etiological criteria (idiopathic or secondary forms) and  
- immunological criteria (ANCA-associated vasculitis, immune-complex vasculitis or 
caused by anti-basement antibodies). 
3.1 ANCA-associated small vessel vasculitis 
The Chapel Hill Consensus Conference classification defines [Jennette 1994]:  
1. Wegener's granulomatosis,  
2. microscopic polyangiitis and  
3. Churg-Strauss syndrome.  
Renal involvement is present in many systemic diseases, especially in the small vessel 
vasculitis – pointed out by Gallo in the New England Journal of Medicine: "The kidney is 
often a window on systemic disease" [Gallo 1991].  
The suspicion of a pulmonary-renal syndrome in an ANCA-associated systemic vasculitis 
can often be taken from a careful history and thorough clinical examination with detection 
of other vasculitic signs (eye inflammation, intractable rhinitis / sinusitis, skin rashes, 
arthralgia, myalgia or polyneuropathy) (Fig. 2). 
 
 
Fig. 2. General symptoms and signs of organ involvement in systemic small vessels 
vasculitis. 
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 ANCA-vasculitis
 WG MP CSS GP SLE 
Clinical presentation
Vasculitic general 
symptoms
+ + + - + 
Granulomatous 
inflammation
+ - + - - 
Eye involvement + (+) (+) - (+) 
Recurrent asthma 
bronchiale
- - + - - 
Pulmonary-renal 
syndrome possible
+ + (+) + (+) 
Skin (purpura, necrosis) + + + - + 
Gastrointestinal 
symptoms
(+) (+) (+) - (+) 
 WG MP CSS GP SLE 
Laboratory workup  
ANCA
Pr3-antibody 
MPO-antibody
80 - 90 %
~ 70 % 
~ 20 %
80 - 90 % 
~ 30 % 
~ 60 %
50 - 70 %
~ 10 % 
~ 60 %
< 30 % - 
Eosinophilia - - + - - 
Reduced complement 
levels 
- - - - + 
Anti-ds-DNA - - - - + 
Anti-GBM-Ab - - - 95% - 
Histology/Immunohistology
Leucocytoclastic
vasculitis
+ + + - + 
Granulomatous 
inflammation
+ - + - - 
Eosinophil 
granulomatous 
inflammation
 
- 
 
- 
 
+ 
 
- 
 
- 
Kidney Biopsy  
Light microscopy 
necrotising intra- and 
extracapillary 
proliferative GN
necrotising intra-
and extracapillary
proliferative GN
Lupus-
nephritis 
Immunohistology 
pauci-immune GN without 
immune-complex deposits 
 
linear IgG-
deposits in the 
glomerular 
basement  
membrane 
granular 
deposits of 
IgG, IgM, 
IgA and 
complement 
factors 
WG = Wegener's Granulomatosis. MP = microscopic polyangiitis. CSS = Churg-Strauss syndrome.  
GP = Goodpasture's Syndrome SLE = systemic lupus erythematosus. ANCA = antineutrophil 
cytoplasmic antibodies. PR-3 = proteinase-3. MPO = myeloperoxidase. IC = immune complex.  
GBM = Glomerular basement membrane. ds = double strand. 
Table 2. The most important differential diagnoses of pulmonary-renal syndrome with 
clinical features, laboratory and histological findings. 
www.intechopen.com
 
An Update on Glomerulopathies – Clinical and Treatment Aspects 
 
296 
3.1.1 Wegener's granulomatosis  
Wegener's granulomatosis is a necrotizing vasculitis of the small and medium-sized vessels, 
associated with granulomas inflammation of the upper and lower respiratory tract and the 
frequent finding of glomerulonephritis. In active disease in about 90% of cases c-ANCA are 
directed against proteinase 3 (Tab. 1 and 2). Figure 3 shows the predominant symptoms in 
image and Figure 4 in number (at onset and during disease) [Hoffmann 1992].  
 
 
      a bloody rhinitis               b aphthae                           c / d  vasculitic skin involvement  
Fig. 3. Wegener's granulomatosis. 
 
 
Fig. 4. Organ involvement in Wegener's granulomatosis. 
3.1.2 Microscopic polyangiitis  
Microscopic polyangiitis is characterized by a necrotizing vasculitis of small vessels with 
minimal or missing immune deposits and an inflammation of the pulmonary capillaries. 
Typically, there are p-ANCA directed against myeloperoxidase (Tab. 1 and 2) [Jennette 1994 & 
Falk 1997]. Wegener`s granulomatosis and Microscopic polyangiitis shows comparable organ 
involvement, but the symptoms of the upper respiratory tract are usally milder in Microscopic 
polyangiitis, because there is no granulomatous inflammation. Compared to Wegener's 
granulomatosis disease recurrence is rare in patients with Microscopic polyangiitis.  
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3.1.3 Churg-Strauss syndrome  
The Churg-Strauss syndrome is characterized by recurrent asthma attacks and allergic rhinitis, 
an intermittently or permanently detectable eosinophilia (> 1500/mm3) and necrotizing 
granulomas and / or necrotizing arteritis with a Wegner's granulomatosis-like presentation. 
The serological diagnosis is less clear: c-ANCA or anti-PR3-Ab detected only rarely, p-ANCA 
and anti-MPO-Ab can be detected in up to 60% of cases (Tab. 1 and 2) [Hoffmann 1992].  
The Churg-Strauss syndrome can be distinguished clinically (asthma attacks, eosinophilia) 
from Wegener`s granulomatosis or Microscopic polyangiits. Renal involvement is seen in 
approximately 25% of patients. 
3.2 Goodpasture syndrome  
The Goodpasture's syndrome is a rare disease with an incidence of 0.1-1 per million per year 
and affects mainly caucasian males. It is characterized by hemoptysis and / or radiological 
evidence of pulmonary infiltrates and a RPGN, which usually develops after hemoptysis. 
There is the very reliable detection of anti-GBM antibody, the identified antigen is the C-
terminal end of the alpha-3-chain of type IV collagen. The immunohistological workup of 
the renal biopsy shows linear IgG deposits in the glomerular basement membranes (Tab. 1 
and 2) [Goodpasture 1919, Salama 2001, Pusey 2003 & Hudson 2003].  
Compared to the ANCA-associated small vessel vasculitidies (Wegener`s Granulomatosis,  
Microscopic polyangiitis and Churg-Strauss syndrome) there are no other, general vasculitic 
symptoms in patients with Goodpasture syndrome. 
3.3 Immune-complex vasculitis of small vessels  
Immune-complex vasculitidies like 
1. systemic lupus erythematosus,  
2. cryoglobulinemic vasculitis and  
3. Purpura Schoenlein-Hennoch [Markus 1989]  
are important differential diagnostic considerations of the pulmonary-renal syndrome.  
They can be distinguished by the previously described extended-serological diagnostic 
workup.  
3.4 Further differential diagnoses  
If this diagnostic workup is unremarkable, there are several more differential diagnosis:  
1. antiphospholipid syndrome with vasculitis and / or pulmonary embolism  
2. mixed connective tissue diseases (systemic sclerosis, polymyositis)  
3. thrombotic thrombozypenic purpura. 
4. infectious diseases involving kidney and lung (e.g Hanta-virus, cytomegalie-virus, 
Legionella, Mycoplasma, Leptospirosis, tuberculosis, sepsis)  
Moreover, a primary renal disease can lead to a pulmonary disease and mimic the image of 
a pulmonary-renal syndrome:  
1. acute renal failure with pulmonary edema and uremic hemoptysis  
2. thromboembolism in nephrotic syndrome: renal vein thrombosis and/ or pulmonary 
embolism  
3. immunosuppression in renal disease and a pneumonia.  
Conversely, a primary pulmonary disease can lead to renal disease and can mimic the image 
of pulmonary-renal syndrome:  
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1. Infection of the respiratory tract with prerenal renal failure and / or postinfectious 
glomerulonephritis or hematuria in IgA nephropathy  
2. Lung cancer with immune-complex nephritis.  
4. Conclusions 
Since early treatment with the mentioned diseases is critical, the diagnosis has to be 
established quickly - the fast antibody-diagnostic and diagnostic imaging have a central role.  
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